Drug Master Files for: Gilead Sciences Inc
✉ Email this page to a colleague
Gilead Sciences Inc Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
12688 | I | II | 10/7/1997 | GILEAD SCIENCES INC | PMPA GEL |
15661 | I | II | 10/12/2001 | GILEAD SCIENCES INC | FK506LC AND PLACEBO |
16033 | I | II | 6/28/2002 | GILEAD SCIENCES INC | LIPOSOMAL OSI-7904 FOR INJECTION (OSI-7904L) |
16237 | I | II | 11/6/2002 | GILEAD SCIENCES INC | LIPOSOMAL LURTOTECAN FOR INJECTION (OSI-211) |
25187 | A | II | 10/21/2011 | GILEAD SCIENCES INC | ELVITEGRAVIR |
25188 | A | II | 10/24/2011 | GILEAD SCIENCES INC | COBICISTAT ON SILICON DIOXIDE |
9564 | A | II | 3/6/1992 | GILEAD SCIENCES INC | AMBISOME, LIPOSOMAL AMPHOTERICIN B |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information